Publications by authors named "David Digomann"

Claim this Profile
I
Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma.
Franziska Baenke, Antonia Stammberger, Ulrich Sommer, Sascha Brückmann, Felix Merboth, David Digomann

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.
Max Heiduk, Carolin Beer, Sarah Cronjaeger, Emily A Kawaler, Ulrich Sommer, David Digomann

JCI Insight· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision-language models for automated video analysis and documentation in laparoscopic surgery: a proof-of-concept study.
Esther Helene Stueker, Fiona R Kolbinger, Oliver Lester Saldanha, David Digomann, Steffen Pistorius

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer.
David Digomann, Charlotte Reiche, Antonia Stammberger, Tido Willms, Loreen S Rudek

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Blood T Cell Frequencies for Risk Prediction of Postoperative Complications in Pancreatic Cancer Surgery.
Loreen Natusch, Max Heiduk, Anna Klimova, Carolin Beer, Tido Willms, David Digomann

Ann Surg Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.
David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert

NPJ Precis Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer.
Max Heiduk, Anna Klimova, Charlotte Reiche, David Digomann, Carolin Beer

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer.
David Digomann, Johannes Strack, Max Heiduk, Ioana Plesca, Luise Rupp

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer.
Max Heiduk, Ioana Plesca, Jessica Glück, Luise Müller, David Digomann

JCI Insight· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer.
Lena Seifert, Ioana Plesca, Luise Müller, Ulrich Sommer, Max Heiduk, David Digomann

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
David Digomann, Annett Linge, Anna Dubrovska

Autophagy· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
David Digomann, Ina Kurth, Anna Tyutyunnykova, Oleg Chen, Steffen Löck

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis